14 information-security-"https:"-"https:"-"https:"-"Itä-Suomen-yliopisto" Postdoctoral positions at KINGS COLLEGE LONDON
-
are not limited to: natural language processing, large language models, graph learning, prompt engineering, knowledge graphs, knowledge engineering, linked data, web technologies. About the role
-
research environment that is open, welcoming and supportive to all. The faculty-wide initiatives are supported by an active Diversity & Inclusion Team. The Social, Genetic & Developmental Psychiatry (SGDP
-
20 Jan 2026 Job Information Organisation/Company KINGS COLLEGE LONDON Research Field Computer science Researcher Profile Recognised Researcher (R2) Established Researcher (R3) Application Deadline
-
confidential spatial health data, including differential privacy and other secure geospatial data protocols. This research will advance our understanding of how major infectious diseases of concern in the UK
-
, research & development, public health, or with people with lived experience. Understanding of data confidentiality and data security. Downloading a copy of our Job Description Full details of the role and
-
with Dr. Li and in collaboration with national and international interdisciplinary partners based at the UK Health Security Agency (UKHSA), University of Cambridge, Imperial College London, John Hopkins
-
with Dr. Li and in collaboration with national and international interdisciplinary partners based at the UK Health Security Agency (UKHSA), University of Cambridge, Imperial College London, John Hopkins
-
, research & development, public health, or with people with lived experience. Understanding of data confidentiality and data security. Downloading a copy of our Job Description Full details of the role and
-
About us The post is based in the Centre for Society and Mental Health, a cross-Faculty initiative between the Faculty of Social Science and Public Policy (SSPP) and the Institute of Psychiatry
-
About Us The GSTT Asthma Service based at Guy’s Hospital is home to the largest cohort of severe asthma and EGPA patients receiving biologic therapies in the UK offering a unique opportunity to take